Drug Discovery
BenevolentAI Embarks on Strategic Overhaul to Realign with Founding TechBio Mission
BenevolentAI, strategic overhaul, TechBio mission, artificial intelligence, biopharmaceutical development, drug discovery, Kenneth Mulvany
GSK and Relation Therapeutics Collaborate on Fibrosis and Osteoarthritis Research with AI-Driven Approach
Relation Therapeutics, GSK, Fibrosis, Osteoarthritis, AI in drug discovery, Machine learning in biotech
Belharra Therapeutics Reduces Workforce by 40%, Laying Off 21 Employees
Belharra Therapeutics, layoffs, workforce reduction, biotech industry, drug discovery
GSK Partners with Muna Therapeutics to Unlock Novel Alzheimer’s Treatments
Muna Therapeutics, GSK, Alzheimer’s disease, neurodegenerative diseases, spatial transcriptomics, MiND-MAP platform, drug discovery, therapeutic targets.
Novartis and Schrödinger Forge $150M Drug Discovery Partnership with Billions in Potential Milestones
Novartis, Schrödinger, drug discovery pact, $150M upfront payment, multiyear collaboration, multi-target agreement.
Iambic Therapeutics Enhances AI Suite with “Enchant” for Predictive Preclinical Drug Development
Iambic Therapeutics, AI, Enchant, preclinical predictive powers, drug discovery, clinical success prediction
FogPharma Rebrands to Parabilis Medicines, Emphasizing AI-Driven Drug Discovery
FogPharma, Parabilis Medicines, AI capabilities, drug discovery, rebranding
Terray Therapeutics Secures $120M Series B Funding to Advance AI-Driven Small Molecule Drug Development
AI-driven drug discovery, small molecule development, Terray Therapeutics, series B funding, biotechnology, pharmaceutical innovation.
Pfizer and Triana Biomedicines Collaborate on Molecular Glue Discovery for Cancer and Other Diseases in $1.5 Billion Deal
Pfizer, Triana Biomedicines, molecular glue, cancer, oncology, drug discovery, biotechnology, pharmaceuticals
Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies
Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership